Chatbot aims to boost breast cancer screening Follow-Up in underserved women

NCT ID NCT07029490

Recruiting now Knowledge-focused Sponsor: University of Utah Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a chatbot—a digital tool you can use on a phone or computer—can help women understand their mammogram results and remind them to get follow-up care if needed. Researchers will enroll about 2,700 women who recently had a mammogram, and half will get the chatbot in addition to usual care. The goal is to see if the chatbot improves screening adherence and follow-up testing, especially for underserved communities.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: chatbot
What this could lead to: If successful, this could show that a simple digital tool helps more women get timely follow-up after abnormal mammograms, potentially improving early detection.
What could go wrong: This is an early feasibility study, not a treatment trial. The chatbot may not change behavior, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Huntsman Cancer Institute/ University of Utah
RECRUITING

Salt Lake City, Utah, 84108, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.